DelveInsight provides insightful market information to Business and Healthcare professionals through analytical and strategic Reports, which are based on Indication, Mechanism of Actions, Drugs and Global API Manufacturers. The Report spectrum also consists of Specialized Reports on Onco-Immunology, Orphan Diseases, Biologics & Bio-Similars, Gene Therapy, Stem Cells Therapy and other upcoming areas. The Reports are popularly used as a dependable platform by many companies to transform and re-define their business. With a large repository of 3,000+ Marketed Reports, along with a profuse pipeline of upcoming Reports, DelveInsight is the undisputed leader in offering trustworthy market intelligence.
Epidemiology reports represent an overview of the diverse threads of epidemiological research for various indications. DelveInsight conducts extensive primary and secondary research, focusing on prevalence/incidence data, the severity of the disease, and its classification in terms of age, sex and subtypes to provide insightful epidemiological information. These epidemiology reports help in assessing the size of the total addressable market and how market dynamics might change as per forecasted epidemiology data. It also assists in identifying potential markets.
DelveInsight, with expertise in market forecasting, brings together the historical and forecasted market size of various indications in 7 Major Markets (7MM) including US, EU5(UK, France, Germany, Italy and Spain) and RoW (Rest of World)*. In-depth analysis conducted through secondary and primary research helps the buyers in understanding the market dynamics and its futuristic scope. The report provides strategically important competitor information, analysis, and insights which help the clients in developing tactical initiatives. Additionally, the report includes in-detail information on emerging key players who might be responsible for changing market equations for forecasted period. This helps the client in planning collaboration, acquisition, in-licensing and out-licensing strategies by understanding the forecasted market trend.
DelveInsight offers detailed pipeline product profiles for over 750+ indications, 670+ different targets, and 700+ different mechanism of action across various therapeutic areas. These reports provide a detailed profile of all clinical and non-clinical assets covering all research and development activities along with deals, collaborations, licensing and patent information. The reports also include therapeutic assessment for all the active drugs based on molecule type, route, monotherapies and combination therapies. These reports help the client and researchers in identifying emerging players and competitors in their respective therapeutic spaces.
DelveInsight has a wide range of Drug Insight reports that provide detailing of key marketed drugs including its product description, mechanism of action, safety and efficacy data, patent's information and market exclusivity data. The report further contains historical and forecasted sales performance. Additionally, key emerging competitors are also provided which assist in understanding the market competition for the same space. DelveInsight also offers different set of reports, such as API Insights which provide insight into Active Pharmaceutical Ingredients (API) manufacturers for drugs and indications across Europe, US, India and China. These reports help the Generic and Drug Development Companies in demarking opportunities in these fields.
DelveInsights comprehensive reports are full-scale reports that cover competitive landscape (all pipeline and marketed drugs), market size, epidemiology, and market positioning and market evolution. These reports provide one-stop solution for the pharma players who want to step in or develop strategies in the concerned market. Additionally, these reports include unmet needs, market barriers and market drivers which further enhances the understanding of the market and its opportunities.
DelveInsight has a wide range of Drug Insight reports that provide detailing of key marketed drugs including its product description, mechanism of action, safety and efficacy data, patent's information and market exclusivity data. The report further contains historical and forecasted sales performance. Additionally, key emerging competitors are also provided which assist in understanding the market competition for the same space. DelveInsight also offers different set of reports, such as API Insights which provide insight into Active Pharmaceutical Ingredients (API) manufacturers for drugs and indications across Europe, US, India and China. These reports help the Generic and Drug Development companies in demarking opportunities in these fields.
Pharma and healthcare sector has witnessed a revolution in the past few decades, mainly due to research-oriented approach that has improved technologies, developed infrastructures, and increased research in the field of bioscience. The industry has made a great deal of progress with the advent of more specific treatment approaches and enriched technologies. DelveInsight has amplified its report store by adding reports featuring Immuno-Oncology, Gene Therapy, Stem Cells Therapy, Antibody-Drug Conjugates, Car-T cells and much more. These reports provide unlimited data potential and extensive application including therapeutics detailed profile, market size, progress tracking, benchmarking against competitors, analysis of success/failure of therapeutics and designs strategy accordingly.
DelveInsight believes in providing best client support, considering every customer a part of a unique collaboration, with their specific set of demands or needs. We value that uniqueness and offer customization in our reports as per the client demand. DelveInsight ensures maximum possible customization within 10 days’ time frame.
The current era, undoubtedly, is being dominated by technologies, which have either enriched or replaced the existing therapies. Modern technologies have brought in more specific approaches, which has resulted in higher safety and better efficacy.
With the intent of providing clients with potential therapy intelligence, DelveInsight has launched Strategic Reports on Immuno-Oncology, Gene Therapy, Stem Cells Therapy, Antibody-Drug Conjugates and many more.
The Reports are endowed with unlimited data potential and extensive application areas on therapeutics. The key contents in the Reports are: detailed profiles, market size, progress tracking, competitor benchmarking, and reasons behind success / failure of therapeutics and also counter strategies for the failures.
DelveInsight s Special Reports helps the client to transform insight into distinctive competitive advantage.
Additionally, DelveInsight provides its client the unsurpassed flexibility of getting the reports customized according to their specific requirements.